Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Organon Pharma Indonesia Tbk. (SCPI) vs Agung Semesta Sejahtera Tbk. (TARA) Price & Performance

Organon Pharma Indonesia Tbk.Trade
Agung Semesta Sejahtera Tbk.Trade

Price performance (Past 24H)

Key statistics

Organon Pharma Indonesia Tbk. vs Agung Semesta Sejahtera Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Agung Semesta Sejahtera Tbk. trades at Rp32 (market cap 342.37B, 1.56M 24h volume). The key difference: Agung Semesta Sejahtera Tbk. is far larger — about 3.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.

SCPITARA
Market Cap
104.4B342.37B
Volume
1.56M
Lot
15.55K
Turnover
49.77M
Average Price
32
Value
49.77M
Indicative Equilibrium Price
32
Indicative Equilibrium Volume
76

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SCPI
View details

About Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Read more on SCPI

About Agung Semesta Sejahtera Tbk.

PT Sitara Propertindo Tbk (the Company) formerly PT Garda Jaya Prima was established based on Notarial Deed No. 2 dated July 28, 2006 of Patricia Bunandi Panggabean S.H., notary in Jakarta.

Read more on TARA